Accuray Shares Approach Critical Threshold Amid Nasdaq Listing Concerns

Accuray US0043971052

Accuray Incorporated finds its stock trading perilously close to the $1.00 level, a key benchmark for maintaining its listing on the NASDAQ exchange. The current share price presents a stark divergence from the average analyst price target of $4.00. Market observers are now questioning whether the company can uphold the exchange's minimum bid requirement and initiate a meaningful price recovery.

• Current Trading Price: Approximately $0.99 (as of latest session).
• Market Capitalization: Roughly $116.7 million.
• 52-Week Low: $0.91 (recorded in November).
• Consensus Price Target: $4.00, as maintained by analysts including BTIG in a November assessment.

Performance and Recent Trajectory

For its fiscal year 2025, which concluded on June 30, 2025, Accuray reported a significantly narrowed net loss of just $1.59 million. This figure marks a substantial improvement over prior periods and establishes a stronger foundation for upcoming financial results. However, the company's quarterly report for the first quarter of fiscal 2026, released in early November, failed to meet market expectations. Weaker revenue trends disclosed in that update have continued to exert downward pressure on the equity's value.

The present valuation gap between the market price and the $4.00 analyst consensus is pronounced. Research firms such as BTIG reaffirmed a positive long-term outlook in their November commentary. This sustained optimism appears rooted in the notable reduction of cash burn and the enhanced profitability demonstrated in FY2025. The available analysis does not specify further forecasts or adjustments to price targets beyond the established consensus.

Technical and Fundamental Outlook

From a chart perspective, the $0.91 level serves as an immediate technical support zone. Market technicians suggest that a sustained move above the $1.05 threshold would be necessary to alleviate immediate concerns regarding listing compliance and to potentially enable a more durable rally. A pivotal event awaits investors in early February 2026: the release of Accuray's Q2 FY2026 results. This report is widely anticipated to provide critical evidence on whether the company can build upon the operational progress achieved at the end of the previous fiscal year.

In the near term, the stock remains caught between the demonstrable financial improvements of FY2025 and the negative momentum following the disappointing Q1 disclosure. Investors are likely to monitor two clear reference points: the support level at $0.91 and the potential for a climb above $1.05 ahead of the next quarterly earnings announcement.